Sort
141,003 grants matching “cytokine”
Impact of hypoxia on lipid metabolism in obesity-driven breast cancer progression
$609,551Dorothy Teegarden · Purdue University · R01 · FY2024 · CA
TRP Channels and Air Pollution
$609,529Christopher A Reilly · University Of Utah · R01 · FY2024 · ES
TRP Channels and Air Pollution
$609,529Christopher A Reilly · University Of Utah · R01 · FY2020 · ES
TRP Channels and Air Pollution
$609,529Christopher A Reilly · University Of Utah · R01 · FY2023 · ES
Defining how phospholipid signaling networks control Th17 differentiation and effector function
$609,518William Francis Hawse · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Brain pathophysiology in SARS-CoV-2 disease
$609,469Kathryn L Sandberg · Georgetown University · R01 · FY2025 · NS
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
$609,452Jung-Hyun Park · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The role of ABI3 in Alzheimers disease
$609,442Jungsu Kim · Indiana University Indianapolis · R01 · FY2025 · AG
Slit2-ROBO signaling in pericytes and myeloid cells controls vascular development and ocular neovascular disease
$609,439Anne Christine Eichmann · Yale University · R01 · FY2025 · HL
Role of Diabetes in MERS Coronavirus Pathogenesis
$609,387Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2020 · AI
Development of NLRP3 inflammasome inhibitors towards Alzheimer's disease
$609,347Shijun Zhang · Virginia Commonwealth University · R01 · FY2018 · AG
Mechanistic studies of Neurosteroid Analogues
$609,336Steven J Mennerick · Washington University · P50 · FY2023 · MH
FUNCTIONAL PROTEOMICS OF LEUKEMIC MARROW STROMAL CELLS
$609,318Beerelli Seshi · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R33 · FY2006 · CA
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
$609,313Jessica A Hamerman · Benaroya Research Inst At Virginia Mason · R01 · FY2019 · AR
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settings
$609,293Kevin B Urdahl · Seattle Biomedical Research Institute · R01 · FY2017 · AI
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
$609,273Sumithira Vasu · Ohio State University · R01 · FY2023 · CA
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
$609,273Sumithira Vasu · Ohio State University · R01 · FY2025 · CA
Metabolic Reprogramming of the Alveolar Stem Cell Niche in Pulmonary Fibrosis
$609,272Victor John Thannickal · Tulane University Of Louisiana · R01 · FY2024 · HL
Oral digoxin for the treatment of NASH
$609,266Bubu Ama Banini · Yale University · R01 · FY2024 · DK
Core Center
$609,244Antony Rosen · Johns Hopkins University · P30 · FY2013 · AR
Persistent hepatitis C virus replication and immunity in pregnancy
$609,225Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · AI
Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure
$609,220Shyam Sunder Bansal · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · HL
Lnk Regulatory Functions in Hematopoietic Stem Cells
$609,184Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2020 · HL
A dual-acting small molecule for the treatment of type 1 diabetes
$609,183Shiyong Wu · Asake Biotechnology, Llc · R42 · FY2023 · DK
Instructive role of MLL fusion proteins in lineage determination and leukemogenesis
$609,178Michael J Thirman · University Of Chicago · R01 · FY2017 · CA